NEAL KLEIMAN to Hirudin Therapy
This is a "connection" page, showing publications NEAL KLEIMAN has written about Hirudin Therapy.
Connection Strength
0.070
-
Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET). Am Heart J. 2002 May; 143(5):847-53.
Score: 0.054
-
Dynamic prognostication in non-ST-elevation acute coronary syndromes: insights from GUSTO-IIb and PURSUIT. Am Heart J. 2004 Jul; 148(1):62-71.
Score: 0.016